Anti-human vWF Affinity Purified IgG

<strong>Anti-human vWF Affinity Purified IgG </strong>_x000D_ <strong>Catalog number:</strong> B2014458_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Anti-human vWF , Goat, Affinity Purified IgG_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhao YM, Jiang M, Ji SD, He Y, Shen F, Li XM, Ruan CG. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys Biochem Pharmacol. 2013 Apr 1;85(7):945-53._x000D_ 2: Kageyama S, Yamamoto H, Nakazawa H, Yoshimoto R. Anti-human vWF monoclonal antibody, AJvW-2 Fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs Thromb Res. 2001 Mar 1;101(5):395-404._x000D_ 3: Eleftheriadis T, Pissas G, Crespo M, Filippidis G, Antoniadis N, Liakopoulos V, Stefanidis I. The effect of anti‑HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation Mol Med Rep. 2021 May;23(5):355._x000D_ 4: Vinholt PJ, Overgaard M, Diederichsen AC, Mickley H, Poulsen TS, Sand NP, Nybo M, Rasmussen LM. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma Thromb Res. 2013 May;131(5):396-400._x000D_ 5: Kageyama S, Yamamoto H, Yoshimoto R. Anti-human von willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2303-8._x000D_ 6: Gritsch H, Stimpfl M, Turecek PL. Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel Electrophoresis Bio Protoc. 2022 Aug 20;12(16):e4495._x000D_ 7: Azimzadeh A, Romain N, Vermot-Desroches C, Ravanat C, Chenard MP, Wijdenes J, Hervé P, Jaeck D, Wolf P. Antibodies to human adhesion molecules and von Willebrand factor: in vitro cross-species reactivity in the xenotransplantation setting Xenotransplantation. 1998 Nov;5(4):284-91._x000D_ 8: Nichols WL, Gastineau DA, Solberg LA Jr, Mann KG. Identification of human megakaryocyte coagulation factor V Blood. 1985 Jun;65(6):1396-406._x000D_ 9: Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):185-91._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/9298543">10: Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor Br J Pharmacol. 1997 Sep;122(1):165-71. </a>_x000D_ _x000D_ <strong>Products Related to Anti-human vWF Affinity Purified IgG can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>